Tenon Medical, Inc. (TNON)
Market Cap | 6.87M |
Revenue (ttm) | 3.32M |
Net Income (ttm) | -13.72M |
Shares Out | 3.14M |
EPS (ttm) | -27.13 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 97,687 |
Open | 2.210 |
Previous Close | 2.200 |
Day's Range | 2.141 - 2.238 |
52-Week Range | 2.130 - 17.190 |
Beta | 1.92 |
Analysts | Strong Buy |
Price Target | 16.00 (+630.59%) |
Earnings Date | Nov 13, 2024 |
About TNON
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Ga... [Read more]
Financial Performance
In 2023, Tenon Medical's revenue was $2.93 million, an increase of 323.73% compared to the previous year's $691,000. Losses were -$15.58 million, -17.63% less than in 2022.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for TNON stock is "Strong Buy." The 12-month stock price forecast is $16.0, which is an increase of 630.59% from the latest price.
News
Tenon Medical, Inc. (TNON) Q3 2024 Earnings Call Transcript
Tenon Medical, Inc. (NASDAQ:TNON) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Steven Foster - President & CEO Kevin Williamson - CFO Conference Call Participant...
Tenon Medical Reports Third Quarter 2024 Financial Results
~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~ ~ Published Interim Analysis from MAINSAIL™ Study; Post-Mark...
Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company's New Catamaran(R) SE SI Joint Fusion System
~ Procedures Completed in Various Spine & Pain Centers of Excellence Throughout the Country Including in Idaho, Pennsylvania, Minnesota, Arizona and Utah ~ ~ Feedback From Initial Physician Users to S...
Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results
LOS GATOS, CA / ACCESSWIRE / October 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) dis...
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
LOS GATOS, CA / ACCESSWIRE / October 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) dis...
Tenon Medical(R) Announces Issuance of Three U.S. Patents
Further Solidifies International Patent Portfolio and Underscores the Company's Commitment to Innovation of SI Joint Stabilization Systems and Methods LOS GATOS, CA / ACCESSWIRE / October 17, 2024 / T...
Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO
Tenon Now Holds 9 Granted Patents and 26 Pending Applications for the Catamaran® SI Joint Fusion System Worldwide LOS GATOS, CA / ACCESSWIRE / September 19, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("...
Tenon Medical, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
LOS GATOS, CA / ACCESSWIRE / September 17, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joi...
Tenon Medical, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
LOS GATOS, CA / ACCESSWIRE / September 12, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joi...
Tenon(R) Medical Announces the Introduction of the Catamaran(R) SE SI Joint Fusion System
~ New SI Joint Fixation Device Offers a 30% Reduction in Implant Size Providing Physicians Choices for Varying Anatomy and Treatment Strategies with the Catamaran Technology ~ ~ The SE System Can Also...
Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market Clinical Investigation Utilizing the Catamaran(R) SI Joint Fusion System
~ Interim Patient Outcomes Demonstrate Significant Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety Profile at Primary 6-month Analysis ~ ~ Preliminary ...
Tenon Medical Announces 1:8 Reverse Split
LOS GATOS, CA / ACCESSWIRE / September 4, 2024 / Tenon Medical, Inc. ("Tenon" or the "Company") (NASDAQ:TNON), a company transforming care for patients suffering with certain sacroiliac joint disorder...
Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market Clinical Investigation Utilizing the Catamaran(R) SI Joint Fusion System
~ Interim Patient Outcomes Demonstrate Significant Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety Profile at Primary 6-month Analysis ~ ~ Preliminary ...
Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer
LOS GATOS, CA / ACCESSWIRE / August 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (S...
Tenon Medical, Inc. (TNON) Q2 2024 Earnings Call Transcript
Tenon Medical, Inc. (NASDAQ:TNON) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Steven Foster - CEO and President Steven Van Dick - CFO and EVP, Finance and Adminis...
Tenon Medical Reports Second Quarter 2024 Financial Results
~ Second Quarter 2024 Revenue Increased 21% Year-Over-Year ~ ~ Surgical Procedures Increased 7% Year-Over-Year in the Second Quarter 2024 ~ ~ Gross Profit Margin of 52% Marks One Year of Generating Po...
Tenon Medical, Inc. Announces Timing of Second Quarter 2024 Financial Results
LOS GATOS, CA / ACCESSWIRE / July 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) d...
Tenon Medical, Inc. (TNON) Q1 2024 Earnings Call Transcript
Tenon Medical, Inc. (NASDAQ:TNON) Q1 2024 Earnings Conference Call May 14, 2024 4:30 PM ET Company Participants Steven M. Foster - Chief Executive Officer, President and Director Steven Van Dick - Ch...
Tenon Medical Reports First Quarter 2024 Financial Results
~ Revenue Increased 66% Year-Over-Year ~ ~ Surgical Procedures Increased 42% Year-Over-Year ~ ~ Gross Margin Stabilized at 65% Sequentially ~ ~ Catamaran® SI Joint Fusion System Received Positive Fusi...
Tenon Medical, Inc. Announces Timing of First Quarter 2024 Financial Results
LOS GATOS, CA / ACCESSWIRE / April 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) ...
Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors
Experienced Medical Devices Industry Executive Joins Tenon's Board of Directors LOS GATOS, CA / ACCESSWIRE / March 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company tr...
Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System
Preliminary SI Joint Fusion Results Based on Independent Radiologist Review Indicate Robust Fusion at 12-Months Post-Procedure Initial Patient Results Demonstrate Marked Improvements in Pain Scores an...
Tenon Medical, Inc (TNON) Q4 2023 Earnings Call Transcript
Tenon Medical, Inc (TNON) Q4 2023 Earnings Call Transcript
Tenon Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Fourth Quarter 2023 Revenue Increased 192% Year-Over-Year Full Year 2023 Revenue Increased 324% Year-Over-Year Surgical Procedures Increased 179% Year-Over-Year in the Fourth Quarter and 312% for the ...
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results
LOS GATOS, CA / ACCESSWIRE / February 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Join...